A randomized trial comparing a novel sirolimus-eluting bioresorbable scaffold with everolimus-eluting metallic stents in patients with coronary artery disease
One-year clinical outcomes following bioresorbable vascular scaffold implantation in patients presenting with acute coronary syndromes versus stable coronary artery disease: results from RAI registry
Quantitative angiographic analysis in patients with de novo native coronary artery lesions treated with novel poly-l-lactide based sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 Trial